noom.microdose glp 1 Noom Launches Microdose GLP-1 Program, Including Medication and Microhabits Program Not tryin’ to hurt your
Description
Given the challenges obesity poses in this fieldincluding increased perioperative risk, altered musculoskeletal biomechanics, and poorer long-term outcomesGLP-1 agonists may play a valuable role in optimizing orthopedic surgical care
Labs (serum): K = 7.1 mmol/L Creatinine = 3.9 mg/dL (baseline 3.5) ECG: only subtle peaked T waves
3 1
Wu L, Xia M, Duan Y, Zhang L, Jiang H, Hu X, et al
These effects are usually short-lived and often lessen as the body becomes used to the medicine
Umul M, Kse SA, Bilen E, Altuncu AG, Oksay T, Gney M
